{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06212271",
            "orgStudyIdInfo": {
                "id": "854429"
            },
            "organization": {
                "fullName": "University of Pennsylvania",
                "class": "OTHER"
            },
            "briefTitle": "A Mechanistic Clinical Trial of Colchicine in Patients Undergoing Femoral Endarterectomy",
            "officialTitle": "A Randomized, Placebo-Controlled Mechanistic Clinical Trial of Colchicine in Patients Undergoing Femoral Endarterectomy",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-mechanistic-clinical-trial-of-colchicine-in-patients-undergoing-femoral-endarterectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-08",
            "studyFirstSubmitQcDate": "2024-01-08",
            "studyFirstPostDateStruct": {
                "date": "2024-01-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Pennsylvania",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Doris Duke Charitable Foundation",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The goal of this mechanistic clinical trial is to test the effects of reducing inflammatory signaling in femoral artery atherosclerotic plaques. Researchers will compare patients receiving colchicine to patients receiving placebo to determine the effect of colchicine on the inflammatory state of atherosclerotic femoral arteries.",
            "detailedDescription": "Patients with peripheral artery disease who will be undergoing femoral endarterectomy will be randomized 1:1 to receive colchicine (0.6mg oral) or placebo daily for 4 weeks prior to surgery. At the baseline visit, study procedures will be reviewed with eligible participants and the study team will obtain written informed consent. Baseline blood samples for laboratory studies will be collected and assayed. A urine pregnancy test will be done for women of childbearing age prior to starting study intervention. The study team will also obtain one 10 mL tube of research blood for future research. Participants will receive follow-up phone calls with the study team. All eligible participants will be approached for participation in an imaging visit. As part of this imaging visit, participants will undergo non-invasive molecular imaging to evaluate the effects of colchicine on the extent of atherosclerotic plaque macrophage activity as assessed by 18F-FDG PET/CT. At the time of femoral endarterectomy, participants will repeat laboratory tests and have a sample of the femoral artery plaque stored for analysis. Participants will then have a follow-up phone call after the femoral endarterectomy to assess for any adverse events."
        },
        "conditionsModule": {
            "conditions": [
                "Peripheral Artery Disease"
            ],
            "keywords": [
                "colchicine",
                "atherosclerotic cardiovascular disease",
                "peripheral artery disease",
                "atherosclerosis",
                "inflammation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Colchicine",
                    "type": "EXPERIMENTAL",
                    "description": "Colchicine (0.6 mg oral daily for 4-weeks) will be the drug administered in this study.",
                    "interventionNames": [
                        "Drug: Colchicine"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "This arm is a matching placebo that will be administered in the same fashion as the experimental arm.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Colchicine",
                    "description": "See arm description.",
                    "armGroupLabels": [
                        "Colchicine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "See arm description.",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "NLRP-3 inflammasome transcripts in femoral artery plaque specimens",
                    "description": "Expression of NLRP-3 inflammasome transcripts will be measured using RNA sequencing",
                    "timeFrame": "Femoral endarterectomy (Week 4)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma IL6 and hsCRP levels",
                    "description": "Expression of plasma IL6 and hsCRP levels will be measured using RNA sequencing",
                    "timeFrame": "Femoral endarterectomy (Week 4)"
                },
                {
                    "measure": "Atherosclerotic plaque macrophage activity",
                    "description": "Atherosclerotic plaque macrophage activity will be assessed by 18F-FDG PET/CT",
                    "timeFrame": "Femoral endarterectomy (Week 4)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Symptomatic PAD\n2. Require endarterectomy\n3. Age \\> 18 years\n4. Stated willingness to comply with all study procedures and availability for the duration of the study\n\nExclusion Criteria:\n\n1. Use of colchicine or systemic anti-inflammatory medication (eg. tocilizumab) in the past 3 months\n2. Allergy to colchicine\n3. Presence of medication with drug-drug interaction\n4. Acute limb ischemia requiring emergent intervention\n5. Vascular connective tissue disorders\n6. Autoimmune/autoinflammatory disorders\n7. Systemic infection\n8. Blood dyscrasia\n9. Pregnant or lactating women\n10. Uncontrolled diabetes (A1C \\>10%)\n11. History of CrCl \\< 30 mL/minute or ESRD (HD)\n12. History of liver disease or chronically-elevated (\\>3 months) ALT/AST \\> 3.0 x ULN\n13. Claustrophobia",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Thomas Carabuena",
                    "role": "CONTACT",
                    "phone": "215-662-4830",
                    "email": "thomas.carabuena@pennmedicine.upenn.edu"
                },
                {
                    "name": "Kevin Dougherty, MPH",
                    "role": "CONTACT",
                    "phone": "215-662-2243",
                    "email": "kevin.dougherty@pennmedicine.upenn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Michael Levin, MD",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Pennsylvania",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Levin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000058729",
                    "term": "Peripheral Arterial Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000050197",
                    "term": "Atherosclerosis"
                },
                {
                    "id": "D000001161",
                    "term": "Arteriosclerosis"
                },
                {
                    "id": "D000001157",
                    "term": "Arterial Occlusive Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000016491",
                    "term": "Peripheral Vascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M26188",
                    "name": "Atherosclerosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "relevance": "LOW"
                },
                {
                    "id": "M29213",
                    "name": "Peripheral Arterial Disease",
                    "asFound": "Peripheral Artery Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18894",
                    "name": "Peripheral Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4469",
                    "name": "Arteriosclerosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4465",
                    "name": "Arterial Occlusive Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003078",
                    "term": "Colchicine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006074",
                    "term": "Gout Suppressants"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6307",
                    "name": "Colchicine",
                    "asFound": "Japanese",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}